News Daily News BELLO: Drug-Coated Balloons Take on De Novo Lesions vs. DES Caitlin E. Cox November 15, 2012
News Daily News BELLO: Balones recubiertos de Fármacos contra Lesiones De Novo frente a SLF Caitlin E. Cox November 15, 2012
News Daily News Los Balones liberadores de Fármacos arrojan Resultados Positivos en el Tratamiento de la Reestenosis intra stent Jason Kahn October 05, 2012
News Daily News Drug-eluting Balloons Show Positive Results in Treating In-stent Restenosis Jason Kahn October 05, 2012
News Daily News Proximal Protection During Carotid Stenting Reduces Silent Infarcts Jason Kahn September 14, 2012
News Daily News Se Publica el COBRA: El Balón de Crioplastia es Efectivo en Diabéticos con Lesiones de la AFS Caitlin E. Cox September 13, 2012
News Daily News COBRA Published: Cryoplasty Balloon Effective in Diabetic Patients with SFA Lesions Caitlin E. Cox September 13, 2012
News Daily News Renal Stenting Shows Potential for Marked BP Lowering in Uncontrolled Hypertension L.A. McKeown September 10, 2012
News Daily News Los Refinamientos de la Braquiterapia arrojan Resultados Positivos en la Re-estenosis Intra-Stent September 05, 2012
News Daily News Brachytherapy Refinements Yield Positive Results in Peripheral In-Stent Restenosis September 05, 2012
News Daily News COMFORTABLE AMI Published: Biodegradable-Polymer DES Bests BMS in STEMI Yael L. Maxwell August 23, 2012
News Daily News Study Suggests Shortening Delay to Noncardiac Surgery After PCI Yael L. Maxwell August 17, 2012
News Daily News Meta-analysis: Paclitaxel-Coated Balloon Reduces TLR in Femoropopliteal Disease August 07, 2012
News Daily News RESET Published: Comparable Efficacy, Safety with EES, SES at 1 Year L.A. McKeown July 30, 2012
News Daily News Meta-analysis: Triple Therapy with Cilostazol Lowers TLR, TVR With No Extra Bleeding Jason Kahn July 13, 2012
News Daily News Reducir el Uso de SLF a la Mitad en Pacientes de Bajo Riesgo podría suponer un Ahorro de 200 millones de Dólares al Año Yael L. Maxwell July 11, 2012
News Daily News Halving DES Use in Low-Risk Patients Could Save $200 Million Annually Yael L. Maxwell July 11, 2012